Copyright
©The Author(s) 2017.
World J Clin Urol. Jul 24, 2017; 6(2): 34-39
Published online Jul 24, 2017. doi: 10.5410/wjcu.v6.i2.34
Published online Jul 24, 2017. doi: 10.5410/wjcu.v6.i2.34
Device | Synergo™ | BWT system™ | Combat™ |
Heat Source | Intravesical 915 MHz microwave antenna (Recirculating cooling system) | External heating plates (Recirculating heating system) | External flat, low volume heat exchanger (Recirculating heating system) |
Temperature and fluctuation | 40 °C-44 °C ± 3 °C | 45 °C | 43.5 °C ± 1 °C |
Priming volume | ± 100 mL | ± 50 mL | ± 30 mL |
Catheter characteristics | 20 Fr. Rigid (Radiofrequency emitter + cooling system inside) | 18 Fr Flexible | 16 Fr Flexible |
Advantages | Strong supporting evidence (neoadjuvant and adjuvant) Long term follow up Proved superior to BCG Proved effectiveness against CIS | Simple and Cheap | Lower dilution of MMC Proved effectiveness in sequential schedules Proved neoadjuvant effectiveness Medium term follow up Simple and Cheap |
Disadvantages | Higher side effects Lower patient tolerance Intravesical Hot and cold spots Expensive device and disposables Continuous machine control required while working | Limited evidence Quick and Turbulent flow + higher temperature (increase hematuria and reduce patient tolerance) | Limited evidence (multicentric studies ongoing) |
- Citation: Flores-Carbajal J, Sousa-Escandón A, Sousa-Gonzalez D, Rodriguez Gomez S, Lopez Saavedra M, Fernandez Martinez ME. Recirculating chemohyperthermia as a treatment for non-muscle invasive bladder cancer: Current and future perspectives. World J Clin Urol 2017; 6(2): 34-39
- URL: https://www.wjgnet.com/2219-2816/full/v6/i2/34.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v6.i2.34